CHI Announces its 2nd Annual Stem Cells in Drug Discovery and Development Conference

Aug. 24, 2011 - PRLog -- Cambridge Healthtech Institute (CHI) announces its second annual Stem Cells in Drug Discovery and Development conference, to be held on November 2-3 at THE US GRANT in San Diego, CA. Sessions will explore how pharma is incorporating stem cells into their drug discovery/development efforts and the value of stem cell models in compound screening, toxicity assessment, disease modeling, and new target discovery.

Confirmed speakers:

Joshua E. Babiarz, Ph.D., Principal Scientist, Non-Clinical Safety, F. Hoffmann-La Roche, Ltd.

Peter Chu, Ph.D., CEO, Eclipse Therapeutics

Markus H. Frank, M.D., Assistant Professor of Pediatrics and Dermatology, Harvard Medical School; Associate Physician, Brigham & Women’s Hospital Transplantation Research Center, Brigham & Women’s Hospital and Children’s Hospital Boston

Robert F. Halliwell, Ph.D., Professor, School of Pharmacy, University of the Pacific

Robert Hollingsworth, Ph.D., Director, Cancer Biology, MedImmune, Inc.

Erica Jackson, Ph.D., Scientist, Cancer Targets, Genentec

Tim Hoey, Ph.D., Senior Vice President, Cancer Biology, OncoMed

Stephen Kelsey, M.D., CMO & Executive Vice President, Oncology, Geron Corp.

Timothy J. Nelson, M.D., Ph.D., Assistant Professor of Medicine and Pharmacology, Mayo Clinic

Marc Peschanski, M.D., Ph.D., Head, Stem Cell Research and Therapy, I-Stem

Marsha Roach, Ph.D., Executive Vice President, Research & Development, GigaCyte

Hirdesh Uppal, Ph.D., Scientist, Genentech

Alex Shcheglovitov, Ph.D., Postdoctoral Fellow, Department of Neurobiology, Stanford University

Robert Tressler, Ph.D., Vice President, Research & Development, Cellerant Therapeutics

Yinghui Zhou, Ph.D., Principal Scientist, AVEO Pharmaceuticals

To view the agenda & speaker abstracts and to register, please visit http://www.healthtech.com/stemcells. Those that register by August 26 will save up to $400.

To inquire about sponsoring and/or exhibiting, contact Carol Dinerstein, 781-972-5471, dinerstein@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com